Augmont Enterprises IPO GMP signals around a 40% listing premium. The IPO’s subscription status and key dates are also mentioned in the article. However, the evidence does not provide detailed information about the IPO’s subscription status or key dates.
The article does not specify the exact dates of the IPO or the subscription period. It only mentions that the GMP signals around a 40% listing premium. The article does not provide any information about whether the IPO is open for subscription or not.
The article is from ET Now, a financial news channel, and it discusses the Augmont Enterprises IPO. The article does not provide any information about the company’s financials, products, or services. It only focuses on the IPO’s GMP and listing premium.
The article does not provide any information about whether the reader should subscribe to the IPO or not. It only presents the information available at the time of writing and leaves the decision to the reader.